Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026)
Verastem (VSTM) recorded quarterly Shares Outstanding (Weighted Average) of $98.3 million in Q1 2026, up 1066.09% quarter-over-quarter from $8.4 million in Q4 2025, and up 81.44% on a YoY basis from $54.2 million in Q1 2025.
Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026) Analysis & Trends
Verastem's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $98.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 81.44% year-over-year to $98.3 million; the TTM figure through Mar 2026 stood at $98.3 million (up 81.44% YoY), while the FY2025 annual figure was $8.4 million, down 53.39% from the prior year.
- Shares Outstanding (Weighted Average) was $98.3 million for Q1 2026 at Verastem, up from $8.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $186.3 million in Q1 2022 to a low of $8.4 million in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $41.5 million across 5 years, with a median of $22.1 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) tumbled 91.02% in 2023, then soared 146.38% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $16.1 million in 2022, then surged by 36.66% to $22.1 million in 2023, then dropped by 18.0% to $18.1 million in 2024, then sank by 53.39% to $8.4 million in 2025, then soared by 1066.09% to $98.3 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $98.3 million (Q1 2026), $8.4 million (Q4 2025), and $64.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 417.01 Bn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 928.40 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 98.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.29 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 64.56 Mn |
| Jun 30, 2025 | 66.14 Mn |
| Mar 31, 2025 | 54.17 Mn |
| Dec 31, 2024 | 18.08 Mn |
| Sep 30, 2024 | 31.35 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 26.83 Mn |
| Dec 31, 2023 | 22.05 Mn |
| Sep 30, 2023 | 20.45 Mn |
| Jun 30, 2023 | 17.73 Mn |
| Mar 31, 2023 | 16.72 Mn |
| Dec 31, 2022 | 16.14 Mn |
| Sep 30, 2022 | 16.43 Mn |
| Jun 30, 2022 | 15.53 Mn |
| Mar 31, 2022 | 186.26 Mn |
| Dec 31, 2021 | 14.54 Mn |
| Sep 30, 2021 | 179.86 Mn |
| Jun 30, 2021 | 171.99 Mn |